UK markets closed

Guardant Health, Inc. (GH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
18.26-0.42 (-2.25%)
At close: 04:00PM EDT
17.94 -0.32 (-1.75%)
After hours: 06:48PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
563,948
563,948
449,538
373,653
286,730
Cost of revenue
227,052
227,052
156,325
122,912
92,535
Gross profit
336,896
336,896
293,213
250,741
194,195
Operating expenses
Research development
367,194
367,194
373,807
263,221
149,862
Selling general and administrative
451,027
451,027
463,784
398,521
299,283
Total operating expenses
901,621
901,621
837,591
661,742
449,145
Operating income or loss
-564,725
-564,725
-544,378
-411,001
-254,950
Interest expense
2,578
2,578
2,577
2,577
4,766
Total other income/expenses net
53,174
53,174
-112,563
25,178
3,641
Income before tax
-478,764
-478,764
-653,449
-384,470
-245,904
Income tax expense
685
685
1,139
300
379
Income from continuing operations
-479,449
-479,449
-654,588
-384,770
-246,283
Net income
-479,449
-479,449
-654,588
-405,670
-253,783
Net income available to common shareholders
-479,449
-479,449
-654,588
-405,670
-253,783
Basic EPS
-4.00
-4.28
-6.41
-4.00
-2.60
Diluted EPS
-4.00
-4.28
-6.41
-4.00
-2.60
Basic average shares
101,314
111,988
102,178
101,314
97,504
Diluted average shares
101,314
111,988
102,178
101,314
97,504